Logo image of VISTN.OL

VISTIN PHARMA ASA (VISTN.OL) Stock Price, Forecast & Analysis

Europe - Euronext Oslo - OSL:VISTN - NO0010734122 - Common Stock

20.2 NOK
-0.3 (-1.46%)
Last: 1/21/2026, 7:00:00 PM

VISTN.OL Key Statistics, Chart & Performance

Key Statistics
Market Cap895.67M
Revenue(TTM)454.83M
Net Income(TTM)78.06M
Shares44.34M
Float18.21M
52 Week High27.3
52 Week Low19.4
Yearly DividendN/A
Dividend Yield5.87%
EPS(TTM)1.76
PE11.48
Fwd PEN/A
Earnings (Next)02-16
IPO2015-06-10
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
VISTN.OL short term performance overview.The bars show the price performance of VISTN.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15

VISTN.OL long term performance overview.The bars show the price performance of VISTN.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10

The current stock price of VISTN.OL is 20.2 NOK. In the past month the price decreased by -1.46%. In the past year, price decreased by -13.68%.

VISTIN PHARMA ASA / VISTN Daily stock chart

VISTN.OL Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

VISTN.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to VISTN.OL. While VISTN.OL has a great health rating, its profitability is only average at the moment.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

VISTN.OL Financial Highlights

Over the last trailing twelve months VISTN.OL reported a non-GAAP Earnings per Share(EPS) of 1.76. The EPS increased by 27.2% compared to the year before.


Industry RankSector Rank
PM (TTM) 17.16%
ROA 18.36%
ROE 24.96%
Debt/Equity 0.07
Chartmill High Growth Momentum
EPS Q2Q%11.83%
Sales Q2Q%2.84%
EPS 1Y (TTM)27.2%
Revenue 1Y (TTM)7.38%

VISTN.OL Forecast & Estimates


Analysts
Analysts40
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

VISTN.OL Ownership

Ownership
Inst Owners14.3%
Ins Owners4.89%
Short Float %N/A
Short RatioN/A

About VISTN.OL

Company Profile

VISTN logo image Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The firm is engaged in the pharmaceuticals industry. The firm is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.

Company Info

VISTIN PHARMA ASA

Ostensjoveien 27

Oslo OSLO NO

Employees: 73

VISTN Company Website

VISTN Investor Relations

Phone: 4748926506

VISTIN PHARMA ASA / VISTN.OL FAQ

What does VISTN do?

Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The firm is engaged in the pharmaceuticals industry. The firm is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.


What is the current price of VISTN stock?

The current stock price of VISTN.OL is 20.2 NOK. The price decreased by -1.46% in the last trading session.


What is the dividend status of VISTIN PHARMA ASA?

VISTIN PHARMA ASA (VISTN.OL) has a dividend yield of 5.87%. The yearly dividend amount is currently 0.


How is the ChartMill rating for VISTIN PHARMA ASA?

VISTN.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the market capitalization of VISTN stock?

VISTIN PHARMA ASA (VISTN.OL) has a market capitalization of 895.67M NOK. This makes VISTN.OL a Small Cap stock.